Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial. [electronic resource]
Producer: 19960821Description: 1001-4 p. digitalISSN:- 0250-7005
- Adenocarcinoma -- drug therapy
- Adjuvants, Immunologic -- adverse effects
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Combined Modality Therapy
- Female
- Humans
- Ifosfamide -- administration & dosage
- Immunity, Cellular -- drug effects
- Immunotherapy
- Interferon-alpha -- administration & dosage
- Leukopenia -- chemically induced
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Thymalfasin
- Thymosin -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.